FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Atkinson James G. 		2. Issuer Name and Ticker or Trading Symbol

VIVEVE MEDICAL, INC. [ VIVE ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CBO & President
(Last)          (First)          (Middle)

345 INVERNESS DR. SOUTH, BUILDING B, SUITE 250 		3. Date of Earliest Transaction (MM/DD/YYYY)

1/29/2019
(Street)

ENGLEWOOD, CO 80112
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   1/29/2019     A    42420   (1) A $0   53945   D    
Common Stock                  621237   I   By IRA   (2)
Common Stock                  285599   I   By Trust   (3)
Common Stock                  3825   I   By Custodian for Child   (4)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received a restricted stock award of 42,420 shares of common stock on January 29, 2019 (the "Grant Date"). The restricted stock award shall vest in full upon the FDA approval of the Viveve System for improvement of sexual function or stress urinary incontinence (SUI) in the United States.
(2)  Shares directly beneficially owned by an individual retirement account created for the benefit of the reporting person (the "IRA"). The reporting person is the beneficiary of the IRA.
(3)  Shares directly beneficially owned by Atkinson Family Revocable Trust Dated 08/26/2013 (the "Trust"). The reporting person a trustee and a co-beneficiary of the Trust.
(4)  Shares purchased pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as custodian for a minor child.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Atkinson James G.
345 INVERNESS DR. SOUTH, BUILDING B
SUITE 250
ENGLEWOOD, CO 80112

CBO & President

Signatures
/s/ James G. Atkinson 2/8/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Viveve Medical (NASDAQ:VIVE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Viveve Medical Charts.
Viveve Medical (NASDAQ:VIVE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Viveve Medical Charts.